IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease
Open Access
- 7 April 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death & Disease
- Vol. 2 (4), e142
- https://doi.org/10.1038/cddis.2011.17
Abstract
To through light on the mechanisms underlying the stimulation and persistence of glial cell activation in Parkinsonism, we investigate the function of IFN-γ and TNF-α in experimental models of Parkinson's disease and analyze their relation with local glial cell activation. It was found that IFN-γ and TNF-α remained higher over the years in the serum and CNS of chronic Parkinsonian macaques than in untreated animals, accompanied by sustained glial activation (microglia and astroglia) in the substantia nigra pars compacta. Importantly, Parkinsonian monkeys showed persistent and increasing levels of IFN-γR signaling in both microglial and astroglial cells. In addition, experiments performed in IFN-γ and TNF-α KO mice treated with MPTP revealed that, even before dopaminergic cell death can be observed, the presence of IFN-γ and TNF-α is crucial for microglial and astroglial activation, and, together, they have an important synergistic role. Both cytokines were necessary for the full level of activation to be attained in both microglial and astroglial cells. These results demonstrate that IFN-γ signaling, together with the contribution of TNF-α, have a critical and cell-specific role in stimulating and maintaining glial cell activation in Parkinsonism.This publication has 38 references indexed in Scilit:
- Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseNature Genetics, 2010
- Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's diseaseJournal of Neuroimmunology, 2009
- IFN-γ receptor signaling mediates spinal microglia activation driving neuropathic painProceedings of the National Academy of Sciences of the United States of America, 2009
- A Nurr1/CoREST Pathway in Microglia and Astrocytes Protects Dopaminergic Neurons from Inflammation-Induced DeathCell, 2009
- Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson diseaseJCI Insight, 2008
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's diseaseBrain, 2008
- In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brainThe Journal of Experimental Medicine, 2006
- Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatumJournal of Neurochemistry, 2004
- Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-α in rat primary astrocytesLife Sciences, 2001
- Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's diseaseGlia, 1993